ACARYON is a pioneering brand dedicated to the microbiome field, with a vision to harness the potential of the gut microbiome for human health. Founded by Philippe Ulsemer, who has over 17 years of experience in the field, and Kawe Toutounian, with more than 15 years of expertise, ACARYON is at the forefront of microbiome and probiotic research. ACARYON's team also includes Peter Götz, a Biotechnology professor with extensive experience in bioprocessing manufacturing.

Further adding to their management team is Christina Sander, who brings 20 years of international financing and marketing experience, and Ina Krüger, a business consultant with a background in biotechnology. The brand has an impressive track record, having developed unique assays, isolated thousands of strains from the human microbiome, and conducted numerous studies on the health potential of the microbiome. They have also developed groundbreaking Next Generation Probiotics, including one with cancer prevention properties, and obtained Novel Food Status and GRAS Status for a new Microorganism.

With the goal of bridging the gap between research findings and concrete applications, ACARYON is currently developing an innovative in vitro human microbiome model. This model aims to accurately mimic natural gut conditions, enabling high throughput analysis of the human microbiome for over 48 hours. With financial support from the EU and the state of Berlin, ACARYON is poised to revolutionize microbiome research and pave the way for targeted applications in the field of human health